openPR Logo
Press release

Global G-CSF And G-CSF Biosimilars Market 2025| By Top Key Players Pfizer, Novartis, Roche, Merck & Co. And More

02-26-2019 12:17 PM CET | IT, New Media & Software

Press release from: Research Trades

Global G-CSF And G-CSF Biosimilars Market 2025| By Top Key

G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.

Request Sample Copy of Report @ https://www.researchtrades.com/request-sample/1664081

This report studies the global G-CSF and G-CSF Biosimilars market status and forecast, categorizes the global G-CSF and G-CSF Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon

Request for discount @ https://www.researchtrades.com/discount/1664081

Table of Contents

Global G-CSF and G-CSF Biosimilars Market Research Report 2018
1 G-CSF and G-CSF Biosimilars Market Overview
1.1 Product Overview and Scope of G-CSF and G-CSF Biosimilars
1.2 G-CSF and G-CSF Biosimilars Segment by Type (Product Category)
1.2.1 Global G-CSF and G-CSF Biosimilars Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global G-CSF and G-CSF Biosimilars Production Market Share by Type (Product Category) in 2017
1.2.3 Blood Disorders
1.2.3 Oncology Diseases
1.2.5 Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
1.3 Global G-CSF and G-CSF Biosimilars Segment by Application
1.3.1 G-CSF and G-CSF Biosimilars Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Human Growth Hormone
1.3.3 Erythropoietin
1.3.4 Monoclonal Antibodies
1.3.5 Insulin
1.3.6 Interferon
1.4 Global G-CSF and G-CSF Biosimilars Market by Region (2013-2025)
1.4.1 Global G-CSF and G-CSF Biosimilars Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of G-CSF and G-CSF Biosimilars (2013-2025)
1.5.1 Global G-CSF and G-CSF Biosimilars Revenue Status and Outlook (2013-2025)
1.5.2 Global G-CSF and G-CSF Biosimilars Capacity, Production Status and Outlook (2013-2025)

2 Global G-CSF and G-CSF Biosimilars Market Competition by Manufacturers
2.1 Global G-CSF and G-CSF Biosimilars Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global G-CSF and G-CSF Biosimilars Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global G-CSF and G-CSF Biosimilars Production and Share by Manufacturers (2013-2018)
2.2 Global G-CSF and G-CSF Biosimilars Revenue and Share by Manufacturers (2013-2018)
2.3 Global G-CSF and G-CSF Biosimilars Average Price by Manufacturers (2013-2018)
2.4 Manufacturers G-CSF and G-CSF Biosimilars Manufacturing Base Distribution, Sales Area and Product Type
2.5 G-CSF and G-CSF Biosimilars Market Competitive Situation and Trends
2.5.1 G-CSF and G-CSF Biosimilars Market Concentration Rate
2.5.2 G-CSF and G-CSF Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

Browse Full Report With TOC @ https://www.researchtrades.com/report/global-g-csf-and-g-csf-biosimilars-market-research-report-2019/1664081

3 Global G-CSF and G-CSF Biosimilars Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global G-CSF and G-CSF Biosimilars Capacity and Market Share by Region (2013-2018)
3.2 Global G-CSF and G-CSF Biosimilars Production and Market Share by Region (2013-2018)
3.3 Global G-CSF and G-CSF Biosimilars Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global G-CSF and G-CSF Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America G-CSF and G-CSF Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe G-CSF and G-CSF Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China G-CSF and G-CSF Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan G-CSF and G-CSF Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia G-CSF and G-CSF Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India G-CSF and G-CSF Biosimilars Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 Global G-CSF and G-CSF Biosimilars Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global G-CSF and G-CSF Biosimilars Consumption by Region (2013-2018)
4.2 North America G-CSF and G-CSF Biosimilars Production, Consumption, Export, Import (2013-2018)
4.3 Europe G-CSF and G-CSF Biosimilars Production, Consumption, Export, Import (2013-2018)
4.4 China G-CSF and G-CSF Biosimilars Production, Consumption, Export, Import (2013-2018)
4.5 Japan G-CSF and G-CSF Biosimilars Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia G-CSF and G-CSF Biosimilars Production, Consumption, Export, Import (2013-2018)
4.7 India G-CSF and G-CSF Biosimilars Production, Consumption, Export, Import (2013-2018)



About Research Trades:
Research Trades has team of experts who works on providing exhaustive analysis pertaining to market research on a global basis. This comprehensive analysis is obtained by a thorough research and study of the ongoing trends and provides predictive data regarding the future estimations, which can be utilized by various organizations for growth purposes.

Contact Information:
Email: sales@researchtrades.com
Call us: +1 6269994607 / +91 7507349866
Skype ID: researchtradescon
Web: www.researchtrades.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global G-CSF And G-CSF Biosimilars Market 2025| By Top Key Players Pfizer, Novartis, Roche, Merck & Co. And More here

News-ID: 1617333 • Views:

More Releases from Research Trades

Global Online Dating Software Market Size, Status And Forecast 2019-2025
Global Online Dating Software Market Size, Status And Forecast 2019-2025
Online Dating Software status, future forecast, growth opportunity, key market and key players. Buy Now@ https://www.researchtrades.com/checkout/1784024 The study objectives are to present the Online Dating Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study SkaDate AdvanDate DatingScript Chameleon PG Dating Pro Badoo Grindr Match Group Spark Networks MeetMe, Inc Zoosk, Inc. Market segment by Type, the product can be split into: Annually Subscription, Quarterly Subscription, Monthly Subscription, Weekly Subscription Market segment
Global Big Data In Aerospace And Defence Market Size, Status And Forecast 2019-2025
Global Big Data In Aerospace And Defence Market Size, Status And Forecast 2019-2 …
Big Data in Aerospace and Defence status, future forecast, growth opportunity, key market and key players. Buy Now@ https://www.researchtrades.com/checkout/1780612 The study objectives are to present the Big Data in Aerospace and Defence development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Cloudera Hewlett Packard Enterprise Hitachi IBM Microsoft Oracle Palantir Technologies SAP SAS Institute Teradata Cisco Systems Google Amazon Airbus Defense and Space Accenture Cyient Market segment by Type, the product can be split into: Structured,

More Releases for Biosimilars

Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Biosimilars Market Size During the Forecast Period? The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth? The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased. According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million